Financial Ratios | Glaxosmithkline Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1278.9539.3 (+3.17 %)
PREV CLOSE (Rs.) 1239.65
OPEN PRICE (Rs.) 1244.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2262
TODAY'S LOW / HIGH (Rs.)1239.05 1285.30
52 WK LOW / HIGH (Rs.)1230.7 1734.9
NSE1279.0038.85 (+3.13 %)
PREV CLOSE( Rs. ) 1240.15
OPEN PRICE (Rs.) 1242.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1279.00 (3)
VOLUME 196020
TODAY'S LOW / HIGH(Rs.) 1239.05 1283.00
52 WK LOW / HIGH (Rs.)1231 1734

Financial Ratios

Select year
ParticularsMar2022Mar2021Mar2020Mar2019Mar2018
Operational & Financial Ratios
   Earnings Per Share (Rs)100.0421.145.5026.2941.41
   CEPS(Rs)26.5021.6010.3829.1622.95
   DPS(Rs)90.0030.0040.0020.0035.00
   Book NAV/Share(Rs)157.1987.26107.47126.31242.89
   Tax Rate(%)51.1236.7269.5234.7635.05
Margin Ratios
   Core EBITDA Margin(%)21.1719.1419.5519.2117.47
   EBIT Margin(%)21.7114.649.2821.8418.65
   Pre Tax Margin(%)21.6514.539.0921.8218.65
   PAT Margin (%)10.589.192.7714.2412.11
   Cash Profit Margin (%)12.4811.715.2315.7913.42
Performance Ratios
   ROA(%)10.119.521.725.774.93
   ROE(%)18.3917.424.7121.2217.26
   ROCE(%)37.7227.7415.7632.5426.56
   Asset Turnover(x)0.961.040.620.410.41
   Sales/Fixed Asset(x)5.963.043.346.488.21
   Working Capital/Sales(x)1.793.684.475.634.94
Efficiency Ratios
   Fixed Capital/Sales(x)0.170.330.300.150.12
   Receivable days21.3418.4211.9615.6020.03
   Inventory Days54.8560.1452.6257.5658.36
   Payable days139.50119.53106.45122.52115.38
Valuation Parameters
   PER(x)16.6268.13226.3349.4425.18
   PCE(x)62.7566.69119.9444.5845.44
   Price/Book(x)10.5816.5111.5910.298.59
   Yield(%)5.412.083.211.541.68
   EV/Net Sales(x)7.847.946.216.675.70
   EV/Core EBITDA(x)30.6732.8027.1829.6529.21
   EV/EBIT(x)32.8950.8064.1230.5230.30
   EV/CE(x)5.687.726.622.672.14
   M Cap / Sales8.598.346.547.046.15
Growth Ratio
   Net Sales Growth(%)12.05-9.273.088.94-1.27
   Core EBITDA Growth(%)18.19-3.744.7125.4813.88
   EBIT Growth(%)70.7146.60-54.3226.495.62
   PAT Growth(%)32.55208.21-79.0726.994.13
   EPS Growth(%)373.19284.26-79.07-36.504.13
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)2.181.631.741.201.20
   Quick Ratio(x)1.871.221.261.021.03
   Interest Cover(x)391.29129.5649.261232.592856.45
   Total Debt/Mcap(x)0.00